Exercise or conversion by Jaya Goyal of 1677 shares of PepGen subject to Rule 16b-3
PEPG Stock | USD 4.48 0.07 1.59% |
Roughly 62% of PepGen's investor base is looking to short. The analysis of the overall investor sentiment regarding PepGen suggests that many traders are alarmed. The current market sentiment, together with PepGen's historical and current headlines, can help investors time the market. In addition, many technical investors use PepGen stock news signals to limit their universe of possible portfolio assets.
PepGen |
Filed transaction by Pepgen Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
PepGen's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the PepGen's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
PepGen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards PepGen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PepGen Fundamental Analysis
We analyze PepGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PepGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PepGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
PepGen is currently under evaluation in target price category among its peers.
PepGen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PepGen stock to make a market-neutral strategy. Peer analysis of PepGen could also be used in its relative valuation, which is a method of valuing PepGen by comparing valuation metrics with similar companies.
Peers
PepGen Related Equities
IPSC | Century Therapeutics | 7.44 | ||||
PHVS | Pharvaris | 6.28 | ||||
MOLN | Molecular Partners | 6.24 | ||||
ANTX | AN2 Therapeutics | 3.73 | ||||
CCCC | C4 Therapeutics | 3.06 | ||||
RLYB | Rallybio Corp | 2.94 | ||||
CGEM | Cullinan Oncology | 2.62 | ||||
TYRA | Tyra Biosciences | 2.21 | ||||
MLYS | Mineralys Therapeutics, | 1.68 | ||||
TRDA | Entrada Therapeutics | 1.28 | ||||
CMPX | Compass Therapeutics | 0.67 | ||||
EWTX | Edgewise Therapeutics | 0.68 | ||||
PMVP | Pmv Pharmaceuticals | 1.24 | ||||
PRTC | PureTech Health | 2.13 | ||||
ELYM | Eliem Therapeutics | 2.60 | ||||
MNOV | MediciNova | 3.76 | ||||
VIGL | Vigil Neuroscience | 5.64 |
Complementary Tools for PepGen Stock analysis
When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |